Literature DB >> 9169743

Effects of adenosine on the functions of circulating polymorphonuclear leukocytes during hyperdynamic endotoxemia.

M Thiel1, K Holzer, U Kreimeier, S Moritz, K Peter, K Messmer.   

Abstract

Endotoxin-activated polymorphonuclear leukocytes (PMNL) adhere to the vascular endothelium and cause damage by the release of toxic superoxide anions (O2-). Because adenosine is a potent inhibitor of PMNL in vitro, the present study investigates the effects of this nucleoside on the functions of circulating PMNL in a standardized porcine model of hyperdynamic endotoxemia. Ten anesthesized pigs received an intravenous (i.v.) 330-min infusion of endotoxin (5 microg/kg of body weight per h). Another 10 pigs were also infused with endotoxin plus adenosine (150 microg/kg/min [i.v.]); this treatment was begun 30 min prior to the beginning of endotoxin treatment. Control groups (five animals per group) received either adenosine or physiological saline. Infusion of endotoxin caused severe neutropenia, shedding of L-selectin, upregulation of beta2-integrins, increased binding of C3-coated zymosan particles, and subsequent phagocytosis by PMNL. While phagocytosis-induced production of oxygen radicals appeared to decrease, extracellular release of superoxide anions was strongly enhanced. Infusion of adenosine during endotoxemia had no effect on neutropenia, expression of adhesion molecules, C3-induced adhesion, phagocytosis, or intracellular production of oxygen radicals, whereas extracellular release of O2- was strongly inhibited. Thus, i.v. infusion of adenosine during endotoxemia could be useful in protecting from O2(-)-mediated tissue injury without compromising the bactericidal mechanisms of PMNL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9169743      PMCID: PMC175295          DOI: 10.1128/iai.65.6.2136-2144.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Ca2+-dependent and Ca2+-independent phagocytosis in human neutrophils.

Authors:  D P Lew; T Andersson; J Hed; F Di Virgilio; T Pozzan; O Stendahl
Journal:  Nature       Date:  1985 Jun 6-12       Impact factor: 49.962

2.  The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers.

Authors:  E L Mills; T Thompson; B Björkstén; D Filipovich; P G Quie
Journal:  Pediatrics       Date:  1979-03       Impact factor: 7.124

3.  Pattern of formylmethionyl-leucyl-phenylalanine-induced luminol- and lucigenin-dependent chemiluminescence in human neutrophils.

Authors:  C Dahlgren; H Aniansson; K E Magnusson
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

Review 4.  Adenosine receptors and their modulators.

Authors:  C E Müller; T Scior
Journal:  Pharm Acta Helv       Date:  1993-09

5.  Measurement of adenosine, inosine, and hypoxanthine in human plasma.

Authors:  J Ontyd; J Schrader
Journal:  J Chromatogr       Date:  1984-05-11

6.  Adenosine; a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils.

Authors:  B N Cronstein; E D Rosenstein; S B Kramer; G Weissmann; R Hirschhorn
Journal:  J Immunol       Date:  1985-08       Impact factor: 5.422

7.  Activation of the human neutrophil respiratory burst with zymosan-activated serum.

Authors:  R J Smith; S S Iden; B J Bowman
Journal:  Biochem Biophys Res Commun       Date:  1984-06-15       Impact factor: 3.575

8.  Intra- and extracellular events in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  G Briheim; O Stendahl; C Dahlgren
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

9.  Role of myeloperoxidase in luminol-dependent chemiluminescence of polymorphonuclear leukocytes.

Authors:  C Dahlgren; O Stendahl
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

10.  Complement and tumor necrosis factor-alpha contribute to Mac-1 (CD11b/CD18) up-regulation and systemic neutrophil activation during endotoxemia in vivo.

Authors:  R Witthaut; A Farhood; C W Smith; H Jaeschke
Journal:  J Leukoc Biol       Date:  1994-01       Impact factor: 4.962

View more
  8 in total

Review 1.  Regulation of neutrophil function by adenosine.

Authors:  Kathryn E Barletta; Klaus Ley; Borna Mehrad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

Review 2.  Adenosine and adenosine receptors in the pathogenesis and treatment of rheumatic diseases.

Authors:  Bruce N Cronstein; Michail Sitkovsky
Journal:  Nat Rev Rheumatol       Date:  2016-11-10       Impact factor: 20.543

3.  Fructose protects murine hepatocytes from tumor necrosis factor-induced apoptosis by modulating JNK signaling.

Authors:  Tobias Speicher; Ulrike A Köhler; Alexander Choukèr; Sabine Werner; Timo Weiland; Albrecht Wendel
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

4.  Adenosine and adenosine receptors: Newer therapeutic perspective.

Authors:  S Manjunath; Pranavkumar M Sakhare
Journal:  Indian J Pharmacol       Date:  2009-06       Impact factor: 1.200

5.  In vivo hypoxic preconditioning protects from warm liver ischemia-reperfusion injury through the adenosine A2B receptor.

Authors:  Alexander Choukèr; Akio Ohta; André Martignoni; Dmitriy Lukashev; Lefteris C Zacharia; Edwin K Jackson; Jürgen Schnermann; Jerrold M Ward; Ines Kaufmann; Brenda Klaunberg; Michail V Sitkovsky; Manfred Thiel
Journal:  Transplantation       Date:  2012-11-15       Impact factor: 4.939

6.  Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway.

Authors:  Alexander Choukèr; Manfred Thiel; Dmitriy Lukashev; Jerrold M Ward; Ines Kaufmann; Sergey Apasov; Michail V Sitkovsky; Akio Ohta
Journal:  Mol Med       Date:  2008 Mar-Apr       Impact factor: 6.354

7.  Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury.

Authors:  Manfred Thiel; Alexander Chouker; Akio Ohta; Edward Jackson; Charles Caldwell; Patrick Smith; Dmitry Lukashev; Iris Bittmann; Michail V Sitkovsky
Journal:  PLoS Biol       Date:  2005-05-03       Impact factor: 8.029

8.  The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.

Authors:  Nalan Kayhan; Benjamin Funke; Lars Oliver Conzelmann; Harald Winkler; Stefan Hofer; Jochen Steppan; Heinfried Schmidt; Hubert Bardenheuer; Christian-Friedrich Vahl; Markus A Weigand
Journal:  Crit Care       Date:  2008-10-13       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.